Skip to content
Screener

Pulse Biosciences, Inc. PLSE Free cash flow margin

Free cash flow margin at other companies

Abbott logo
AbbottABT
16.8%+1.1pp
Johnson & Johnson logo
Johnson & JohnsonJNJ
22.7%+2.2pp
Boston Scientific logo
Boston ScientificBSX
16.9%-0.3pp
AtriCure logo
AtriCureATRC
9.3%—
Medtronic logo
MedtronicMDT
14.9%-0.5pp
Merit Medical Systems logo
Merit Medical SystemsMMSI
14.3%+1.3pp

Other financials

Income statement

See full
Revenue$434.0K—
Gross profit$161.0K—
Operating income-$25.3M-24.6%
Net income-$24.7M-28.6%
EPS (diluted)-$0.49-2.1%

Balance sheet

See full
Cash & equivalents$101.6M-4.4%
Total debt$6.8M-17.9%
Total equity$99.5M-4.8%
Total assets$115.6M-3.9%

Cash flow

See full
Operating cash flow-$18.7M-46.1%
CapEx$90.0K-12.6%
Free cash flow-$18.8M-45.6%

Valuation

See full
Market cap$2.65B+156%
Enterprise value$2.55B+173%
P/S2,233.4×—

Profitability

See full
Gross margin-0.1%—
Operating margin-7,007.8%—
Net margin-6,755.8%—

Returns & leverage

See full
Return on equity-78.5%-15.3pp
Debt / equity0.1×0.0×
Current ratio9.6×-2.4×

Where this comes from

Calculated from Pulse Biosciences, Inc.’s reported figures.

free cash flow/total revenue=-5,180.4%

Based on trailing twelve months.

The source filing: Pulse Biosciences, Inc.’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 4:23 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001437749-26-026288

FAQ

What is Pulse Biosciences, Inc.'s free cash flow margin?
Pulse Biosciences, Inc. (PLSE) reported free cash flow margin of -5,180.4% in Q2 2026.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.

Ask your AI about Pulse Biosciences, Inc.'s free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude